AXRX — Amexdrug Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Amexdrug, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2008 December 31st	2009 December 31st	2010 December 31st	2011 December 31st	2012 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	0.012	0.018	0.189	0.101	0.082
Depreciation
Deferred Taxes
Non-Cash Items	0.023	0.015	0.039	-0.012	-0.016
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.232	-0.107	0.03	-0.272	-0.317
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-0.194	-0.063	0.227	-0.137	-0.161
Capital Expenditures	-0.002	-0.01	-0.004	-0.042	-0.459
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.003	-0.01	-0.001	0.003	-0.002
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-0.005	-0.02	-0.005	-0.04	-0.461
Financing Cash Flow Items	-0.018	0.003	-0.003	0.004	-0.011
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.078	0.107	0.101	0.323	0.448
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.121	0.025	0.323	0.146	-0.174